Published in J Diabetes Sci Technol on January 01, 2009
Managing diabetes with nanomedicine: challenges and opportunities. Nat Rev Drug Discov (2014) 1.39
Overview of fluorescence glucose sensing: a technology with a bright future. J Diabetes Sci Technol (2012) 0.90
Glucose Measurement by Affinity Sensor and Pulsed Measurements of Fluidic Resistances: Proof of Principle. J Diabetes Sci Technol (2014) 0.78
Feasibility of an Orthogonal Redundant Sensor incorporating Optical plus Redundant Electrochemical Glucose Sensing. J Diabetes Sci Technol (2016) 0.75
Polymer optical fiber compound parabolic concentrator tip for enhanced coupling efficiency for fluorescence based glucose sensors. Biomed Opt Express (2015) 0.75
Options for the Development of Noninvasive Glucose Monitoring: Is Nanotechnology an Option to Break the Boundaries? J Diabetes Sci Technol (2016) 0.75
Sensing glucose concentrations at GHz frequencies with a fully embedded Biomicro-electromechanical system (BioMEMS). J Appl Phys (2013) 0.75
High Affinity Mannotetraose as an Alternative to Dextran in ConA Based Fluorescent Affinity Glucose Assay Due to Improved FRET Efficiency. ACS Sens (2016) 0.75
Evaluating the accuracy of continuous glucose-monitoring sensors: continuous glucose-error grid analysis illustrated by TheraSense Freestyle Navigator data. Diabetes Care (2004) 4.31
Accuracy of the 5-day FreeStyle Navigator Continuous Glucose Monitoring System: comparison with frequent laboratory reference measurements. Diabetes Care (2007) 3.65
The accuracy of the FreeStyle Navigator continuous glucose monitoring system in children with type 1 diabetes. Diabetes Care (2007) 3.11
A fluorescence-based glucose biosensor using concanavalin A and dextran encapsulated in a poly(ethylene glycol) hydrogel. Anal Chem (1999) 2.07
Glucose monitoring by reverse iontophoresis. Diabetes Metab Res Rev (2002) 1.80
Affinity sensor: a new technique for developing implantable sensors for glucose and other metabolites. Diabetes Care (1983) 1.65
Impact of posture and fixation technique on impedance spectroscopy used for continuous and noninvasive glucose monitoring. Diabetes Technol Ther (2004) 1.53
In vitro long-term performance study of a near-infrared fluorescence affinity sensor for glucose monitoring. Biosens Bioelectron (2004) 1.32
In vivo performance evaluation of a transdermal near- infrared fluorescence resonance energy transfer affinity sensor for continuous glucose monitoring. Diabetes Technol Ther (2006) 1.15
Noninvasive glucose monitoring in diabetic patients: a preliminary evaluation. Clin Chem (1992) 1.14
Human plasma-derived mannose-binding lectin: a phase I safety and pharmacokinetic study. Scand J Immunol (2004) 1.13
Viscosimetric affinity assay. Anal Biochem (1996) 1.05
Glucose sensors based on microcapsules containing an orange/red competitive binding resonance energy transfer assay. Diabetes Technol Ther (2006) 0.96
Glucose monitoring: state of the art and future possibilities. Med Eng Phys (1996) 0.95
Clinical performance of a continuous viscometric affinity sensor for glucose. Diabetes Technol Ther (2004) 0.92
Zero-order release of lysozyme from poly(ethylene glycol)/poly(butylene terephthalate) matrices. J Control Release (2000) 0.91
The polymer Polyactive as a bone-filling substance: an experimental study in rabbits. J Mater Sci Mater Med (1998) 0.82
Evaluation of subcutaneously-implanted glucose sensors for continuous glucose measurements in hyperglycemic pigs. In Vivo (2006) 0.81
Strategies for coupling digital filtering with partial least-squares regression: application to the determination of glucose in plasma by Fourier transform near-infrared spectroscopy. Anal Chem (1993) 0.81
Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab (2011) 1.67
The metabolic syndrome is frequent in Klinefelter's syndrome and is associated with abdominal obesity and hypogonadism. Diabetes Care (2006) 1.52
The Danish Centre for Strategic Research in Type 2 Diabetes (DD2) study: implementation of a nationwide patient enrollment system. Clin Epidemiol (2012) 1.32
Premixed insulin treatment for type 2 diabetes: analogue or human? Diabetes Obes Metab (2007) 1.31
Basal and insulin mediated VLDL-triglyceride kinetics in type 2 diabetic men. Diabetes (2010) 1.07
Growth hormone-induced insulin resistance is associated with increased intramyocellular triglyceride content but unaltered VLDL-triglyceride kinetics. Am J Physiol Endocrinol Metab (2006) 1.07
Incidence of GH deficiency - a nationwide study. Eur J Endocrinol (2006) 1.01
Risk for nocturnal hypoglycemia with biphasic insulin aspart 30 compared with biphasic human insulin 30 in adults with type 2 diabetes mellitus: a meta-analysis. Clin Ther (2009) 0.97
Free fatty acids decrease circulating ghrelin concentrations in humans. Eur J Endocrinol (2006) 0.96
Somatropin and glucose homeostasis: considerations for patient management. Treat Endocrinol (2002) 0.94
Impact of body composition on very-low-density lipoprotein-triglycerides kinetics. Am J Physiol Endocrinol Metab (2008) 0.93
Energy expenditure, insulin, and VLDL-triglyceride production in humans. J Lipid Res (2006) 0.93
Increased VLDL-triglyceride secretion precedes impaired control of endogenous glucose production in obese, normoglycemic men. Diabetes (2011) 0.93
Ghrelin immunoreactivity in human plasma is suppressed by somatostatin. Clin Endocrinol (Oxf) (2002) 0.92
The aging population--is there a role for endocrine interventions? Growth Horm IGF Res (2008) 0.92
Dilation of the ascending aorta in Turner syndrome - a prospective cardiovascular magnetic resonance study. J Cardiovasc Magn Reson (2011) 0.92
HER-2 DNA and protein vaccines containing potent Th cell epitopes induce distinct protective and therapeutic antitumor responses in HER-2 transgenic mice. J Immunol (2003) 0.91
Growth hormone and glucose homeostasis. Horm Res (2004) 0.90
A 4-mm needle reduces the risk of intramuscular injections without increasing backflow to skin surface in lean diabetic children and adults. Diabetes Care (2008) 0.89
Thoracic aortopathy in Turner syndrome and the influence of bicuspid aortic valves and blood pressure: a CMR study. J Cardiovasc Magn Reson (2010) 0.89
Effects of free fatty acids, growth hormone and growth hormone receptor blockade on serum ghrelin levels in humans. Clin Endocrinol (Oxf) (2007) 0.87
Insulin and GH signaling in human skeletal muscle in vivo following exogenous GH exposure: impact of an oral glucose load. PLoS One (2011) 0.87
Carotid-femoral pulse wave velocity is associated with cerebral white matter lesions in type 2 diabetes. Diabetes Care (2012) 0.86
Postabsorptive VLDL-TG fatty acid storage in adipose tissue in lean and obese women. Obesity (Silver Spring) (2009) 0.85
Effects of exercise on VLDL-triglyceride oxidation and turnover. Am J Physiol Endocrinol Metab (2011) 0.85
Evaluation of a glucose sensing antibody using weak affinity chromatography. Biomed Chromatogr (2008) 0.83
Ambulatory arterial stiffness index in Turner syndrome: the impact of sex hormone replacement therapy. Horm Res (2009) 0.83
Effects of growth hormone on glucose and fat metabolism in human subjects. Endocrinol Metab Clin North Am (2007) 0.82
Effect of hyperinsulinemia during hemodialysis on the insulin-like growth factor system and inflammatory biomarkers: a randomized open-label crossover study. BMC Nephrol (2013) 0.82
Serum levels of bioactive IGF1 and physiological markers of ageing in healthy adults. Eur J Endocrinol (2013) 0.82
Long-term DHEA substitution in female adrenocortical failure, body composition, muscle function, and bone metabolism: a randomized trial. Eur J Endocrinol (2011) 0.82
Combined heart rate- and accelerometer-assessed physical activity energy expenditure and associations with glucose homeostasis markers in a population at high risk of developing diabetes: the ADDITION-PRO study. Diabetes Care (2013) 0.81
Insertion of foreign T cell epitopes in human tumor necrosis factor alpha with minimal effect on protein structure and biological activity. J Biol Chem (2004) 0.81
Impaired insulin-mediated antilipolysis and lactate release in adipose tissue of upper-body obese women. Obesity (Silver Spring) (2011) 0.81
Long-term hormone replacement therapy preserves bone mineral density in Turner syndrome. Eur J Endocrinol (2009) 0.81
Serum insulin-like growth factor I levels in growth hormone-deficient adults: influence of sex steroids. Horm Res (2004) 0.81
Independent effects of testosterone on lipid oxidation and VLDL-TG production: a randomized, double-blind, placebo-controlled, crossover study. Diabetes (2012) 0.81
Delayed β-cell response and glucose intolerance in young women with Turner syndrome. BMC Endocr Disord (2011) 0.80
The effects of capillary dysfunction on oxygen and glucose extraction in diabetic neuropathy. Diabetologia (2014) 0.80
Plasma ghrelin levels during exercise in healthy subjects and in growth hormone-deficient patients. Eur J Endocrinol (2002) 0.80
Acute and short-term chronic testosterone fluctuation effects on glucose homeostasis, insulin sensitivity, and adiponectin: a randomized, double-blind, placebo-controlled, crossover study. J Clin Endocrinol Metab (2014) 0.79
Similar VLDL-TG storage in visceral and subcutaneous fat in obese and lean women. Diabetes (2011) 0.78
Effects of insulin-like growth factor-I administration on in vivo regulation of urea synthesis in normal subjects and patients with cirrhosis. Liver Int (2010) 0.78
Peroxisome proliferator-activated receptor gamma agonism modifies the effects of growth hormone on lipolysis and insulin sensitivity. Clin Endocrinol (Oxf) (2008) 0.77
Clinical aspects of growth hormone deficiency in adults. An overview. Front Horm Res (2005) 0.77
Dehydroepiandrosterone supplementation in women with adrenal failure: impact on twenty-four hour GH secretion and IGF-related parameters. Clin Endocrinol (Oxf) (2004) 0.77
Influence of insulin and free fatty acids on contractile function in patients with chronically stunned and hibernating myocardium. Am J Physiol Heart Circ Physiol (2005) 0.77
Explorative study of pharmacokinetics and pharmacodynamics after change in basal insulin infusion rate. J Diabetes Sci Technol (2011) 0.75
Overnight versus 24 hours of continuous subcutaneous insulin infusion as supplement to oral antidiabetic drugs in type 2 diabetes. J Diabetes Sci Technol (2007) 0.75
Normalisation of insulin-like growth factor-I does not improve insulin action in cirrhosis. Liver Int (2011) 0.75
Discontinuation of hormone replacement therapy in young GH-treated hypopituitary women increases liver enzymes. Growth Horm IGF Res (2009) 0.75
Reproducibility of pulse wave analysis and pulse wave velocity in patients with type 2 diabetes. Scand J Clin Lab Invest (2013) 0.75
Impaired postprandial response of the insulin-like growth factor system in maintenance haemodialysis. Clin Endocrinol (Oxf) (2013) 0.75
Isolated hyperglycaemia does not increase VLDL-triacylglycerol secretion in type 1 diabetic men. Diabetologia (2014) 0.75
Socioeconomic factors do not but GH treatment does affect mortality in adult-onset growth hormone deficiency. J Clin Endocrinol Metab (2014) 0.75
Towards a FRET-based immunosensor for continuous carbohydrate monitoring. J Immunol Methods (2008) 0.75
Age dimorphism in the association between growth-hormone status and the respiratory quotient. Obes Res (2002) 0.75